Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Phase 2 Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid

NCT03092765 is registered in ClinicalTrials.gov with EA Pharma Co., Ltd. as lead sponsor.

NCT NCT03092765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03092765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Phase 2 Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid
Lead sponsor
EA Pharma Co., Ltd.
Phase
Phase 2
Overall status
Terminated
Start date
May 29, 2017
Completion date
October 22, 2018
Enrollment
29 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cholangitis